par Fratino, Sara
;Garré, Annalisa;Garufi, Alessandra;Hafidi, Sofia
;Migliorino, Ernesto;Stropeni, Serena;Gouvêa Bogossian, Elisa
;Djangang, Narcisse Ndieugnou;Albano, Giovanni;Creteur, Jacques
;Peluso, Lorenzo
;Taccone, Fabio 
Référence Anaesthesia Critical Care and Pain Medicine, 42, 2, page (101175)
Publication Publié, 2023-04-01






Référence Anaesthesia Critical Care and Pain Medicine, 42, 2, page (101175)
Publication Publié, 2023-04-01
Article révisé par les pairs
Résumé : | This prospective observational study included 80 adults (>18 years) patients admitted to the intensive care unit who were unconscious (Glasgow Coma Scale [GCS] score <9 with a motor response <5) and receiving mechanical ventilation. A tetanic stimulation was used to assess nociception; automated pupillometry (Algiscan, ID-MED, France) was used to compute the pupillary pain index score (PPI), with a PPI > 4 considered as nociception. Concomitantly, the number of skin conductance fluctuations (NSCF) per second, measured using a Skin Conductance Algesimeter (SCA, MEDSTORM Innovation AS, Norway; > 0.27 fluctuations/sec indicating nociception), and the instantaneous Analgesia Nociception Index (iANI, MDoloris Medical Systems, France; <50 indicating nociception) were collected. Tetanic stimulation resulted in a median pupillary dilation of 16 [6–25]% and a PPI of 5 [2–7]. According to the PPI assessment, 44 patients (55%) had nociception, whereas 23 (29%) and 18 (23%) showed nociception according to the algesimeter and iANI assessment, respectively. No significant changes in measured physiologic variables were observed after the tetanic stimulation. There were no correlations between PPI, post-stimulation iANI, and SCA-derived variables. There were no differences in PPI, iANI, and SCA variables in patients with low and normal baseline EEG power at baseline. Perspectives: Detection of nociception varies across different devices in unconscious critically ill patients. Further studies are required to understand which method to implement for analgesic administration in this patient population. |